Literature DB >> 29289717

Exploring the Interaction Between eIF2α Dysregulation, Acute Endoplasmic Reticulum Stress and DYT1 Dystonia in the Mammalian Brain.

Genevieve Beauvais1, Noela Rodriguez-Losada2, Lei Ying1, Zuchra Zakirova3, Jaime L Watson1, Ben Readhead3, Paul Gadue4, Deborah L French4, Michelle E Ehrlich3, Pedro Gonzalez-Alegre5.   

Abstract

DYT1 dystonia is a neurological disease caused by dominant mutations in the TOR1A gene, encoding for the endoplasmic reticulum (ER)-resident protein torsinA. Recent reports linked expression of the DYT1-causing protein with dysregulation of eIF2α, a key component of the cellular response to ER stress known as the unfolded protein response (UPR). However, the response of the DYT1 mammalian brain to acute ER stress inducers has not been evaluated in vivo. We hypothesized that torsinA regulates the neuronal UPR and expression of its mutant form would alter this process. TorsinA was post-transcriptionally upregulated upon acute ER stress in different models, suggesting a role in this response. Moreover, increased basal phosphorylation of eIF2α in DYT1 transgenic rats was associated with an abnormal response to acute ER stress. Finally, an unbiased RNA-Seq-based transcriptomic analysis of embryonic brain tissue in heterozygous and homozygous DYT1 knockin mice confirmed the presence of eIF2α dysregulation in the DYT1 brain. In sum, these findings support previous reports linking torsinA function, eIF2α signaling and the neuronal response to ER stress in vivo. Furthermore, we describe novel protocols to investigate neuronal ER stress in cultured neurons and in vivo.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ER stress; TorsinA; UPR; dystonia; eif2α

Mesh:

Substances:

Year:  2017        PMID: 29289717     DOI: 10.1016/j.neuroscience.2017.12.033

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia.

Authors:  Jay Li; Daniel S Levin; Audrey J Kim; Samuel S Pappas; William T Dauer
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 2.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

3.  A truncated PACT protein resulting from a frameshift mutation reported in movement disorder DYT16 triggers caspase activation and apoptosis.

Authors:  Samuel B Burnett; Lauren S Vaughn; Joelle M Strom; Ashley Francois; Rekha C Patel
Journal:  J Cell Biochem       Date:  2019-06-27       Impact factor: 4.429

4.  DYT-PRKRA Mutation P222L Enhances PACT's Stimulatory Activity on Type I Interferon Induction.

Authors:  Lauren S Vaughn; Kenneth Frederick; Samuel B Burnett; Nutan Sharma; D Cristopher Bragg; Sarah Camargos; Francisco Cardoso; Rekha C Patel
Journal:  Biomolecules       Date:  2022-05-17

5.  The abnormal firing of Purkinje cells in the knockin mouse model of DYT1 dystonia.

Authors:  Yuning Liu; Hong Xing; Bradley J Wilkes; Fumiaki Yokoi; Huanxin Chen; David E Vaillancourt; Yuqing Li
Journal:  Brain Res Bull       Date:  2020-09-22       Impact factor: 4.077

6.  Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Radhika F Kadakia; Yuping Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2021-04-21       Impact factor: 5.996

7.  Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function.

Authors:  Lilian Cruz; Bence György; Pike See Cheah; Benjamin P Kleinstiver; William A Eimer; Sara P Garcia; Nutan Sharma; Laurie J Ozelius; D Cristopher Bragg; J Keith Joung; Osmar Norberto de Souza; Luis Fernando Saraiva Macedo Timmers; Xandra O Breakefield
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-15       Impact factor: 8.886

8.  EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia.

Authors:  Demy J S Kuipers; Wim Mandemakers; Chin-Song Lu; Simone Olgiati; Guido J Breedveld; Christina Fevga; Vera Tadic; Miryam Carecchio; Bradley Osterman; Lena Sagi-Dain; Yah-Huei Wu-Chou; Chiung C Chen; Hsiu-Chen Chang; Shey-Lin Wu; Tu-Hsueh Yeh; Yi-Hsin Weng; Antonio E Elia; Celeste Panteghini; Nicolas Marotta; Martje G Pauly; Andrea A Kühn; Jens Volkmann; Baiba Lace; Inge A Meijer; Krishna Kandaswamy; Marialuisa Quadri; Barbara Garavaglia; Katja Lohmann; Peter Bauer; Niccolò E Mencacci; Steven J Lubbe; Christine Klein; Aida M Bertoli-Avella; Vincenzo Bonifati
Journal:  Ann Neurol       Date:  2020-12-15       Impact factor: 10.422

9.  Inhibition of endoplasmic reticulum stress reverses synaptic plasticity deficits in striatum of DYT1 dystonia mice.

Authors:  Huaying Cai; Linhui Ni; Xingyue Hu; Xianjun Ding
Journal:  Aging (Albany NY)       Date:  2021-08-16       Impact factor: 5.682

Review 10.  Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia.

Authors:  Damiana Scuteri; Kengo Hamamura; Chizuko Watanabe; Paolo Tonin; Giacinto Bagetta; Maria Tiziana Corasaniti
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.